Hofseth BioCare ASA (OSTO:HBCO) COGS-to-Revenue : 0.52 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Hofseth BioCare ASA COGS-to-Revenue?

Hofseth BioCare ASA's Cost of Goods Sold for the three months ended in Mar. 2024 was kr27.3 Mil. Its Revenue for the three months ended in Mar. 2024 was kr52.4 Mil.

Hofseth BioCare ASA's COGS to Revenue for the three months ended in Mar. 2024 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hofseth BioCare ASA's Gross Margin % for the three months ended in Mar. 2024 was 47.77%.

Hofseth BioCare ASA COGS-to-Revenue Historical Data

The historical data trend for Hofseth BioCare ASA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA COGS-to-Revenue Chart

Hofseth BioCare ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.88

0.57

0.74

0.76

0.77

Hofseth BioCare ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.92	0.51	0.68	1.04	0.52

Hofseth BioCare ASA COGS-to-Revenue Calculation

Hofseth BioCare ASA's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	150.688	/	194.874
	=	0.77

Hofseth BioCare ASA's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.346	/	52.358
	=	0.52

Hofseth BioCare ASA (OSTO:HBCO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hofseth BioCare ASA's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	27.346 / 52.358
	=	47.77 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hofseth BioCare ASA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hofseth BioCare ASA (OSTO:HBCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OSTO:HBCO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

HOFBF:USA HBC:Norway HBQ:Germany

Address

Kipervikgata 13, Aalesund, NOR, 6003

Website

https://www.hofsethbiocare.com

Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (OSTO:HBCO) Headlines

No Headlines